Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trialJordana B. Cohen, Julio A. Chirinos, Thomas C. Hanff et al.|The Lancet Respiratory Medicine|2021Cited by 224
Initial Findings From the North American COVID-19 Myocardial Infarction RegistrySantiago García, Frank V. Aguirre, Nestor Mercado et al.|Journal of the American College of Cardiology|2021Cited by 140
Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial ProtocolJordana B. Cohen, Julio A. Chirinos, Tiffany Sharkoski et al.|Journal of Clinical Hypertension|2020Cited by 19